Literature DB >> 8612208

Cyclin E -- a better prognostic marker for breast cancer than cyclin D?

Q P Dou, A B Pardee, K Keyomarsi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612208     DOI: 10.1038/nm0396-254a

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Cyclin E and chromosome instability in colorectal cancer cell lines.

Authors:  C Simone; N Resta; L Bagella; A Giordano; G Guanti
Journal:  Mol Pathol       Date:  2002-06

2.  AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.

Authors:  Xiang-Yu Kong; Deng-Cheng Zhang; Wen-Xin Zhuang; Su-Hang Hua; Yue Dai; Yang-Yang Yuan; Li-Li Feng; Qian Huang; Bo-Gang Teng; Xiu-Yi Yu; Wen-Zhi Liu; Yong-Xing Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Cyclin E, a redundant cyclin in breast cancer.

Authors:  J Gray-Bablin; J Zalvide; M P Fox; C J Knickerbocker; J A DeCaprio; K Keyomarsi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Novel B, C-ring truncated deguelin derivatives reveals as potential inhibitors of cyclin D1 and cyclin E using molecular docking and molecular dynamic simulation.

Authors:  Kiran Bharat Lokhande; Payel Ghosh; Shuchi Nagar; K Venkateswara Swamy
Journal:  Mol Divers       Date:  2021-10-09       Impact factor: 3.364

5.  Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.

Authors:  Hannah Wingate; Agnes Puskas; Mylinh Duong; Tuyen Bui; Dana Richardson; Yanna Liu; Susan L Tucker; Carolyn Van Pelt; Laurent Meijer; Kelly Hunt; Khandan Keyomarsi
Journal:  Cell Cycle       Date:  2009-04-10       Impact factor: 4.534

6.  Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.

Authors:  Nicole E Willmarth; Donna G Albertson; Stephen P Ethier
Journal:  Breast Cancer Res       Date:  2004-07-06       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.